Back
Coronavirus: WHO halts trials of hydroxychloroquine over safety fears
May 26, 2020
Testing of the malaria drug hydroxychloroquine as a possible treatment for coronavirus has been halted because of safety fears, the World Health Organization (WHO) says.
Trials in several countries are being "temporarily" suspended as a precaution, the agency said on Monday.
It comes after a recent medical study suggested the drug could increase the risk of patients dying from Covid-19.
President Donald Trump has said he is taking the drug to ward off the virus.
The US president has repeatedly promoted the anti-malarial drug, against medical advice and despite warnings from public health officials that it could cause heart problems.
What's known about anti-malarial drugs and Covid-19? 'Baffling' observations from the front line Covid-19: How scared should we be?
Last week, a study in medical journal The Lancet said there were no benefits to treating coronavirus patients with hydroxychloroquine, and that taking it might even increase the number of deaths among those in hospital with the disease.
Hydroxychloroquine is safe for malaria, and conditions like lupus or arthritis, but no clinical trials have recommended its use for treating Covid-19.
Image copyright Getty Images Image caption Researchers say Covid-19 patients should not use hydroxychloroquine outside of clinical trials
The WHO, which is running clinical trials of various drugs to assess which might be beneficial in treating the disease, has previously raised concerns over reports of individuals self-medicating and causing themselves serious harm.
12Shares
0Comments
1Favorites
3Likes
Say something to impress...
Loading...
Comments
Hot

No content at this moment.

Relevant people
BBC News
134121 Followers
News and more.
Related